Literature DB >> 12356828

Effects of endothelin-1 on components of anterograde axonal transport in optic nerve.

Martha E Stokely1, Scott T Brady, Thomas Yorio.   

Abstract

PURPOSE: Increased levels of endothelins (ETs) are associated with glaucoma and have been said to contribute to the development of glaucomatous optic neuropathy. In glaucoma, movement of selected components of anterograde axonal transport essential in ganglion cell survival is impaired-specifically, the transport of mitochondria. This study evaluates the effect(s) of a single administration of intravitreous ET-1 on anterograde axonal transport in the rat optic nerve.
METHODS: Proteins for anterograde axonal transport were pulse labeled by intravitreous injection of (35)S-methionine plus or minus ET-1 (2 nmol) in HEPES buffer (pH 7.4). At appropriate time intervals, optic nerves were dissected, sectioned while frozen, and homogenized in denaturing buffer, and transported protein was quantitated by liquid scintillation counting. Counts corrected for efficiency, quench, background, and decay were statistically evaluated (ANOVA, n = 7).
RESULTS: Effects of treatment with intravitreous ET-1 on anterograde axonal transport were significant, biphasic, and prolonged (4 hours to 21 days). The initial phase was a significant enhancement of transport at times normally associated with small, fast-moving tubulovesicles (4 and 24 hours), followed by significant impairments at times normally associated with transport of mitochondria (28-36 hours), cytoplasmic matrix (4 days), and cytoskeletal proteins (21 days). The most pronounced effect of ET-1 was decreased axonal transport at times associated with normal anterograde transport of mitochondrial proteins (28, 32, and 36 hours, P = < 0.001, P < 0.015, and P < 0.001, respectively). This was mimicked by ET-3 at 28 hours.
CONCLUSIONS: Effects of intravitreous ET-1 are consistent with a receptor-mediated role for elevated ETs in pathologic misregulation(s) of anterograde axonal transport.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2002        PMID: 12356828

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  18 in total

Review 1.  A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma.

Authors:  Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2010-09-16       Impact factor: 3.467

2.  Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma.

Authors:  M Emre; S Orgül; T Haufschild; S G Shaw; J Flammer
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

Review 3.  Critical pathogenic events underlying progression of neurodegeneration in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2012-08-01       Impact factor: 21.198

4.  Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma.

Authors:  Dorota L Stankowska; Alena Z Minton; Margaret A Rutledge; Brett H Mueller; Nitasha R Phatak; Shaoqing He; Hai-Ying Ma; Michael J Forster; Thomas Yorio; Raghu R Krishnamoorthy
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-13       Impact factor: 4.799

Review 5.  Endothelin antagonism as an active principle for glaucoma therapy.

Authors:  Rita Rosenthal; Michael Fromm
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

6.  Endothelin-Mediated Changes in Gene Expression in Isolated Purified Rat Retinal Ganglion Cells.

Authors:  Shaoqing He; Yong H Park; Thomas Yorio; Raghu R Krishnamoorthy
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09-01       Impact factor: 4.799

7.  [Primary open-angle glaucoma and systemic diseases].

Authors:  M Pache
Journal:  Ophthalmologe       Date:  2007-05       Impact factor: 1.059

Review 8.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

9.  Matrix metalloproteinase-9 expression in retinal ganglion cell layer and effect of topically applied brimonidine tartrate 0.2% therapy on this expression in an endothelin-1-induced optic nerve ischemia model.

Authors:  Zeynep Aktas; Gokhan Gurelik; Pinar Uyar Göçün; Nalan Akyürek; Merih Onol; Berati Hasanreisoğlu
Journal:  Int Ophthalmol       Date:  2009-07-21       Impact factor: 2.031

10.  Endothelin-1 mediated regulation of extracellular matrix collagens in cells of human lamina cribrosa.

Authors:  Vidhya R Rao; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  Exp Eye Res       Date:  2008-03-12       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.